PDGFRB upregulation contributes to retinal damages in the rat model of retinal ischemia-reperfusion
Biochemical and Biophysical Research Communications · 2023
DOI: 10.1016/j.bbrc.2023.03.085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023. Verfasst von Juanjuan Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Hospital of Yunnan University (Second People's Hospital of Yunnan Province, Yunnan Eye Hospital), No.176, Qing nian Road, Kunming city, Yu…. Hauptthemen laut MEDLINE: Reperfusion Injury, Retinal Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Retinal ischemic disease is a major type of retinal diseases causing vision loss. Identifying the molecular mechanisms mediating the retinal ischemia-reperfusion (RIR) is the key to targeted intervention. In this study, we performed RNA-seq analysis of the retinal tissues of a retinal ischemia-reperfusion model of Sprague-Dawley (SD) rats, followed by differential gene expression analysis, gene ontology (GO) enrichment analysis, and protein-protein interaction (PPI) analysis. After studying we found that: The major biological processes affected after RIR was the regulation of vascular development. PPI analysis unveiled a regulatory module in which Platelet Derived Growth Factor Receptor Beta (PDGFRB) was upregulated. In the RIR cell model of human retinal microvascular endothelial cells (HRCEC) induced by oxygen-glucose deprivation/reperfusion (OGD/R), silencing PDGFRB at least partially rescued the detrimental effect on cell proliferation and in vitro angiogenic ability. In the rat model of RIR, the administration of PDGFR inhibitor alleviated the damages in the retinal microvascular system. Besides, we further demonstrated the protective effect of procyanidin against RIR induced damages in both the cell and animal model by dampening the overexpression of PDGFRB. Together, our data indicate that the upregulation of PDGFRB contributes to RIR-induced damages in retinal microvascular system, which provides a targetable strategy for therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Affiliated Hospital of Yunnan University (Second People's Hospital of Yunnan Province, Yunnan Eye Hospital), No.176, Qing nian Road, Kunming city, Yunnan Province, 650021, China.
- Affiliated Hospital of Yunnan University (Second People's Hospital of Yunnan Province, Yunnan Eye Hospital), No.176, Qing nian Road, Kunming city, Yunnan Province, 650021, China. Electronic address: 160417116@stu.cuz.ed…
Zitieren
APA
Li, J., Chen, C., Zhang, L., Ren, Y., & Li, H. (2023). PDGFRB upregulation contributes to retinal damages in the rat model of retinal ischemia-reperfusion. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.03.085
Vancouver
Li J, Chen C, Zhang L, Ren Y, Li H. PDGFRB upregulation contributes to retinal damages in the rat model of retinal ischemia-reperfusion. Biochemical and Biophysical Research Communications. 2023. doi:10.1016/j.bbrc.2023.03.085
BibTeX
@article{Li2023,
author = {Li, Juanjuan and Chen, Chen and Zhang, Liwei and Ren, Yuling and Li, Hua},
title = {PDGFRB upregulation contributes to retinal damages in the rat model of retinal ischemia-reperfusion},
journal = {Biochemical and Biophysical Research Communications},
year = {2023},
doi = {10.1016/j.bbrc.2023.03.085}
}
EUVIMED